Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
NCT00185952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2011-06-13
Summary
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Conditions
- Obstetric Labor, Premature
- Venous Thrombosis
Interventions
- DRUG
-
Nifedipine
Nifedipine 10 mg tablets, two tablets orally every 6 hours. Placebo tablets, two tablets orally every 6 hours.
Sponsors & Collaborators
-
Santa Clara Valley Health & Hospital System
collaborator OTHER - lead OTHER
Principal Investigators
-
Yasser Yehia El-Sayed · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Primary Completion
- 2007-01-31
- Completion
- 2008-08-31
Countries
- United States
Study Locations
More Related Trials
-
Two Dose Regimens of Nifedipine for the Management of Preterm Labor
NCT00137501 ·Status: TERMINATED ·Phase: PHASE3
-
Nifedipine Versus Indomethacin in the Treatment of Preterm Labour
NCT01360034 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
NCT03129945 ·Status: COMPLETED ·Phase: NA
-
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
NCT00641784 ·Status: TERMINATED ·Phase: PHASE3
-
Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
NCT00525486 ·Status: TERMINATED ·Phase: NA
-
The Efficacy of Nifedipine in the Management of Preterm Labor
NCT04644354 ·Status: UNKNOWN
-
Nifedipine Treatment in Preterm Labor
NCT01314859 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor
NCT03040752 ·Status: COMPLETED ·Phase: PHASE4
-
Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery
NCT01796522 ·Status: WITHDRAWN ·Phase: PHASE3
-
Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor
NCT02090920 ·Status: COMPLETED
-
Nifedipine Compared to Atosiban for Treating Preterm Labor
NCT00599898 ·Status: COMPLETED ·Phase: PHASE4
-
Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Acute Threatened Preterm Labour
NCT02068404 ·Status: UNKNOWN ·Phase: PHASE4
-
Changes in Central Arterial Pressure of Normotensive Women Taking Nifedipine for Tocolysis
NCT02902354 ·Status: WITHDRAWN ·Phase: NA
-
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
NCT03976063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
NCT02438371 ·Status: TERMINATED ·Phase: PHASE4
-
Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate
NCT06904534 ·Status: ACTIVE_NOT_RECRUITING
-
Nifedipine Versus Magnesium Sulfate for Late Preterm Tocolysis
NCT05343806 ·Status: COMPLETED ·Phase: NA
-
Tocolytic Therapy for Preterm Labor in Multiple Gestation
NCT02725736 ·Status: UNKNOWN ·Phase: PHASE3
-
Management of Acute Preterm Labor: Nifedipen Alone or Combined With Cildenafil Citrate
NCT02337881 ·Status: UNKNOWN ·Phase: PHASE1
-
Tocolysis in Prevention of Preterm Labor
NCT03298191 ·Status: UNKNOWN ·Phase: PHASE4
-
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs
NCT05345132 ·Status: RECRUITING ·Phase: NA
-
Magnesium Sulfate vs Placebo for Placental Abruption
NCT00186069 ·Status: COMPLETED ·Phase: NA
-
Single Versus Combination Therapy in Acute Tocolysis
NCT01429545 ·Status: COMPLETED ·Phase: PHASE2
-
Bryophyllum vs. Nifedipine
NCT00391339 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour
NCT04846621 ·Status: UNKNOWN ·Phase: PHASE2